Silo Pharma, Inc. (SILO) - Rentabilitas operasi

The operating profit margin on the GURU.Markets chart demonstrates financial efficiency, where the -12534.00 metric reflects current dynamics. Silo Pharma, Inc. (SILO) is valued by physicians for its innovations in neurology. The company develops psychedelic treatments for dementia, protecting its research with patents. Market capitalization is based on nasal drug delivery systems and insurance fund reimbursements for PTSD therapy.
Silo Pharma, Inc. - rincian analitis lan metrik utama (SILO)

This indicator assesses the share of profit from core operations relative to total revenue, allowing for an evaluation of cost management efficiency before accounting for financial obligations and taxes. By analyzing the operating margin, an investor can determine how successfully Silo Pharma, Inc. (SILO) converts the uniqueness of its transdermal psilocybin delivery systems and the inelastic demand in psychopharmacology into actual operating income.